Drug Pipeline Progress: Positive clinical trial results or FDA approvals for Ovid Therapeutics' drug candidates typically drive the stock price higher, while setbacks can cause declines. Financial Performance: Revenue, earnings, and cash flow reports influence investor confidence. Strong financial results generally lead to price increases, while losses can negatively impact the stock. Market Sentiment: Overall investor attitudes towards the biotechnology industry or Ovid Therapeutics specifically affect demand and supply, impacting the stock price. Regulatory Landscape: Changes in regulations related to drug development, approval processes, or pricing can significantly affect Ovid Therapeutics and its stock value. Competition: The emergence of competing therapies or technologies can impact Ovid Therapeutics' market share and future prospects, potentially leading to price decreases. Partnerships and Collaborations: Strategic alliances, licensing agreements, or collaborations with other pharmaceutical companies can positively influence investor perception and stock value. Management Changes: Major leadership transitions or strategic shifts within Ovid Therapeutics can create uncertainty and potentially affect the stock price. Macroeconomic Factors: Economic conditions, interest rates, and inflation can indirectly influence investor behavior and the overall stock market, including Ovid Therapeutics' stock.